Malcolm Risk

MedicineMathematics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Online causal inference with application to near real‐time post‐market vaccine safety surveillance”.

Online causal inference with application to near real‐time post‐market vaccine safety surveillance

Statistics in Medicine(2024)10.1002/sim.10095

N/A

0.345DataRank · unranked

9 citations

Malcolm Risk, Xu Shi, Lan Luo

Efficacy of COVID-19 vaccines in patients taking immunosuppressants

Annals of the Rheumatic Diseases(2022)10.1136/annrheumdis-2021-222045

N/A

0DataRank · unranked

68 citations

Malcolm Risk, Elena Schiopu, Salim S. Hayek, Tiankai Xie, Lynn Holevinski +4 more

COVID-19 vaccine effectiveness against omicron (B.1.1.529) variant infection and hospitalisation in patients taking immunosuppressive medications: a retrospective cohort study

The Lancet Rheumatology(2022)10.1016/s2665-9913(22)00216-8

N/A

0DataRank · unranked

64 citations

Salim S. Hayek, Elena Schiopu, Liyang Yuan, Chen Shen, Xu Shi +3 more

Comparative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccines Against the Delta Variant

Clinical Infectious Diseases(2022)10.1093/cid/ciac106

N/A

0DataRank · unranked

30 citations

Chen Shen, Salim S. Hayek, Lynn Holevinski, Elena Schiopu, Gary L. Freed +3 more

Vaccine Effectiveness, School Reopening, and Risk of Omicron Infection Among Adolescents Aged 12–17 Years

Journal of Adolescent Health(2022)10.1016/j.jadohealth.2022.09.006

N/A

0DataRank · unranked

12 citations

Heidi Miao, Gary L. Freed, Chen Shen, Malcolm Risk

Risk benefit analysis to evaluate risk of thromboembolic events after mRNA COVID-19 vaccination and COVID-19

npj Vaccines(2024)10.1038/s41541-024-00960-7

N/A

0DataRank · unranked

8 citations

Malcolm Risk, Girish B. Nair, Lili Zhao, Huong N. Q. Tran